Thyroid Hormone Receptor Interactor 4 (TRIP4) Peptid
Kurzübersicht für Thyroid Hormone Receptor Interactor 4 (TRIP4) Peptid (ABIN8113870)
Target
Quelle
Applikation
-
-
Verwendungszweck
- TRIP4 Peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-TRIP4 antibody ( ARP35908_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- TRIP4 (Thyroid Hormone Receptor Interactor 4 (TRIP4))
-
Hintergrund
-
Background Information: TRIP4 is a transcription coactivator of nuclear receptors which functions in conjunction with CBP-p300 and SRC-1 and may play an important role in establishing distinct coactivator complexes under different cellular conditions. TRIP4 plays a pivotal role in the transactivation of NF-kappa-B, SRF and AP1. TRIP4 acts as a mediator of transrepression between nuclear receptor and either AP1 or NF-kappa-B. It plays a role in androgen receptor transactivation and in testicular function
Alternative Symbols: ASC1, ASC-1, HsT17391
-
Molekulargewicht
- 66kDa
-
Gen-ID
- 9325
-
NCBI Accession
- NP_057297
-
UniProt
- Q15650
Target
-
